Publications by authors named "D Campos-Outcalt"
Article Synopsis
- On June 17, 2024, the FDA approved the 21-valent pneumococcal conjugate vaccine (PCV21) for adults 18 and older, introducing eight new serotypes not in other vaccines.
- The ACIP recommends PCV21 for all adults 65 and older, and for those aged 19-64 with specific health risks if they haven't been previously vaccinated or their vaccination status is unknown.
- ACIP recommends a single dose of PCV21 for adults 19 and older, while maintaining previous indications and guidelines for other pneumococcal vaccines.